Approval · Notice of Compliance 2705 · 1998
NEUROLITE: Notice of Compliance 2705
Issued December 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2705
- Date
- December 4, 1998
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Radiodiagnostic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEUROLITE | Not yet assigned | — |
Medicinal ingredients
- BICISATE DIHYDROCHLORIDE 0.9 MG per VIAL